Also trades as: ACST.V (TSXV) · $vol 0M
ACST NASDAQ
Acasti Pharma Inc.
1W: +5.5%
1M: -3.5%
3M: +38.4%
1Y: +56.9%
3Y: -62.6%
5Y: -96.7%
$3.37
Last traded 2024-11-22 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$67M
-7.4% ▼
5Y CAGR: +1.3%
Total Liabilities
$3M
-48.8% ▼
5Y CAGR: -16.5%
Shareholders Equity
$64M
-4.1% ▼
5Y CAGR: +2.8%
Cash & Investments
$17M
-23.3% ▼
5Y CAGR: -22.5%
Total Debt
$0
+0.0% ▲
Net Debt
-$17M
+23.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $30M | $28M | $23M | $22M | $17M |
| Short-Term Investments | $13M | $15K | $0 | $0 | $0 |
| Cash & ST Investments | $44M | $28M | $23M | $22M | $17M |
| Net Receivables | $548K | $802K | $722K | $126K | $20K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $352K | $0 | $0 | $453K | $383K |
| Total Current Assets | $46M | $29M | $24M | $23M | $17M |
| Property, Plant & Equip. | $315K | $567K | $24K | $0 | $0 |
| Goodwill & Intangibles | $83M | $49M | $49M | $49M | $49M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $15K | $8K |
| Total Non-Current Assets | $83M | $50M | $49M | $49M | $49M |
| Total Assets | $129M | $79M | $73M | $72M | $67M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $1M | $1M | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$1M | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $2M | $2M |
| Total Current Liabilities | $3M | $3M | $2M | $2M | $2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $10K | $0 | $4M | $1M | $0 |
| Total Non-Current Liabilities | $17M | $8M | $10M | $3M | $612K |
| Total Liabilities | $20M | $11M | $12M | $5M | $3M |
| — Equity — | |||||
| Common Stock | $258M | $258M | $261M | $1K | $1K |
| Retained Earnings | -$156M | -$198M | -$211M | -$221M | -$228M |
| Accumulated OCI | -$6M | -$6M | -$6M | -$6M | -$6M |
| Total Stockholders Equity | $108M | $68M | $62M | $67M | $64M |
| Total Liabilities & Equity | $129M | $79M | $73M | $72M | $67M |
| — Key Metrics — | |||||
| Total Debt | $295K | $485K | $0 | $0 | $0 |
| Net Debt | -$30M | -$27M | -$23M | -$22M | -$17M |
| Total Investments | $13M | $15K | $0 | $0 | $0 |